The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]

The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]

From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]

Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum.   Farmaindustria.es Artificial intelligence (AI) is a true revolution […]

The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]

The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]

    1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The […]

For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and […]

EL PAÍS and Farmaindustria address the tasks pending to achieve autonomy in the manufacture of pharmaceuticals. Elpais.com Spain stands out for its strong pharmaceutical industry. It […]

A hundred members of the Spanish Society of Family and Community Medicine and pharmaceutical companies attend a training session to learn about the opportunities offered to […]

After its presentation a few months ago in Andalusia, the guide to bring clinical trials to health centres has been disseminated in Castilla y León and […]

The Association has participated in the Forum on clinical trials organised by the United Nations in the Latin American and Caribbean region together with the Latin […]

Spain is a benchmark country in the world and the first in Europe to conduct clinical trials to test the safety and efficacy of new drugs. […]

Its application should also serve to put an end to repetitive and inefficient evaluations and guarantee rigour for patients and healthcare professionals, who will play an […]

Recruitment forecasts for innovative pharmaceutical companies for the coming years exceed 10,000 new jobs for the under-30s. The website offers practical information about the sector and […]

Funcas and Farmaindustria held a conference on ‘The economic regulation of the pharmaceutical industry. Current situation and future prospects in Spain’, which was attended by more […]

Spain is at the forefront of research. Experts discuss the potential of new medicines at a forum organised by EL PAÍS and Farmaindustria. Elpais.com In the […]

DemócrataPRO brings together the Health Commission to debate on the reform of the law on medicines On 21 March, DemócrataPro brought together the spokespersons of the […]

The Spanish Technological Platform for Innovative Medicines, led by Farmaindustria, has been promoting public-private collaboration projects in clinical and pre-clinical research since 2005. “Spain currently occupies […]

Human papillomavirus is responsible for 95% of cervical tumours. Since 2006, several vaccines have been licensed that can prevent most cases. In Spain, the autonomous communities […]

fundacionidis.com The ecosystem of the private healthcare sector transcends the field of healthcare and has an impact on society and on the productive sectors of the […]

There are 146 orphan drugs approved by the European Medicines Agency. Spain has only 81 in its catalogue. It has rejected funding for 25 and is […]

Research into new drugs for rare diseases has multiplied in recent years. In Spain, industry drives 90% of clinical trials for this type of disease. One […]

In a press release, the Andalusian Regional Government highlights the joint commitment of both entities to continue advancing in the promotion of R&D&I, following the meeting […]

Of the 1,944 clinical trials authorised in the European Union through the new European Information System, Spanish centres participated in 845, or 43% of the total. […]

The European Medicines Agency has thus identified nine oncology approvals for 2023. The arrival of new treatments is directly linked to the pharmaceutical industry’s commitment to […]

The Technological Platform for Innovative Medicines – whose Coordination Committee is made up of 10 representatives from the pharmaceutical industry and 10 representatives from public research […]

Farmaindustria welcomes the presentation by the Ministry of Health of the harmonised catalogue of genetic tests for the whole country. For this catalogue to become a […]

The US expert unpacked the data from his study on the relationship between pharmaceutical innovation and cancer mortality in Spain between 1999 and 2016 in a […]